Back to homepage
Dermatology
Onset of vitiligo following targeted therapy for BRAFV600E-mutated melanoma: case report
This case study covers a patient who received dabrafenib and trametinib and developed vitiligo-like depigmentation after treatment cessation.
Efficacy of topical beta-blockers in the management of EGFR-inhibitor induced paronychia and pyogenic granuloma-like lesions: case series and review of the literature
The authors tested the effectiveness of topical timolol 0.5% gel on paronychia and periungual pyogenic granuloma-like lesions being treated with EGFR-I and reviewed the available literature on this topic, which is the use of topical β-blockers in the management of EGFR-I-induced nail toxicities.
Breakthroughs in hereditary angioedema management: a systematic review of approved drugs and those under research
This review focuses on the mechanisms of action, routes of administration, and efficacy of therapies for the rare genetic disorder hereditary angioedema.
Guselkumab for the treatment of psoriasis – evidence to date
This review highlights the evidence available to date for the use of guselkumab for the treatment of psoriasis. The results of the recent ECLIPSE trial are addressed.
